Odds ratio (with 95% confidence interval) of indirect comparisons of edoxaban versus dabigatran, rivaroxaban and apixaban. Efficacy end-points. Significant comparisons are printed in bold.

Odds ratio (with 95% confidence interval) of indirect comparisons of edoxaban versus dabigatran, rivaroxaban and apixaban. Efficacy end-points. Significant comparisons are printed in bold.依度沙班（edoxaban）与达比加群酯（dabigatran）、利伐沙班（rivaroxaban）及阿哌沙班（apixaban）进行间接比较的比值比（Odds Ratio），附95%置信区间（95% Confidence Interval）。有效性终点（Efficacy End-points）。具有统计学意义的比较以粗体形式呈现。